Literature DB >> 23739775

The natural course and complications of alpha-mannosidosis--a retrospective and descriptive study.

Dag Malm1, Hilde Monica Frostad Riise Stensland, Øyvind Edvardsen, Øivind Nilssen.   

Abstract

Most alpha-mannosidosis patients described have been children and information on the natural course of the disorder has been based on a very limited number of observations. In order to assess the disease presentation in detail and to study disease characteristics, a study was started in 1991 and has been ongoing for over 20 years. Patients with confirmed alpha-mannosidosis were recruited through The International Society for Mannosidosis and Related Diseases (ISMRD) where families affected with alpha-mannosidosis received a questionnaire on general clinical information to be filled out by the responsible physician. The questionnaire was returned by 125 patients (64%). Of these, 45 patients were 15 years old or older at the time of evaluation. The questionnaire allowed us to assess the following features: Facial dysmorphism, columnar disease, arthritis, myopathy, hearing impairment, mental impairment, psychosis, bone disease and motor function as well as general health. This study describes the progression of alpha-mannosidosis and may be helpful in determining the clinical characteristics for assessments of prognosis.

Entities:  

Mesh:

Year:  2013        PMID: 23739775     DOI: 10.1007/s10545-013-9622-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Identification of 83 novel alpha-mannosidosis-associated sequence variants: functional analysis of MAN2B1 missense mutations.

Authors:  Hilde Monica Frostad Riise Stensland; Helle Bagterp Klenow; Lam Van Nguyen; Gaute Martin Hansen; Dag Malm; Øivind Nilssen
Journal:  Hum Mutat       Date:  2012-01-23       Impact factor: 4.878

2.  Purification of bovine lysosomal alpha-mannosidase, characterization of its gene and determination of two mutations that cause alpha-mannosidosis.

Authors:  O K Tollersrud; T Berg; P Healy; G Evjen; U Ramachandran; O Nilssen
Journal:  Eur J Biochem       Date:  1997-06-01

Review 3.  Clarifying lysosomal storage diseases.

Authors:  Mark L Schultz; Luis Tecedor; Michael Chang; Beverly L Davidson
Journal:  Trends Neurosci       Date:  2011-06-30       Impact factor: 13.837

4.  alpha-Mannosidosis: functional cloning of the lysosomal alpha-mannosidase cDNA and identification of a mutation in two affected siblings.

Authors:  O Nilssen; T Berg; H M Riise; U Ramachandran; G Evjen; G M Hansen; D Malm; L Tranebjaerg; O K Tollersrud
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

5.  Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes.

Authors:  D Malm; D S Halvorsen; L Tranebjaerg; H Sjursen
Journal:  Eur J Pediatr       Date:  2000-09       Impact factor: 3.183

6.  The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations.

Authors:  Helena Poupetová; Jana Ledvinová; Linda Berná; Lenka Dvoráková; Viktor Kozich; Milan Elleder
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

7.  Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy.

Authors:  Peter J Meikle; Enzo Ranieri; Henrik Simonsen; Tina Rozaklis; Steve L Ramsay; Phillip D Whitfield; Maria Fuller; Ernst Christensen; Flemming Skovby; John J Hopwood
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

8.  The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation.

Authors:  Pirkko Heikinheimo; Ronny Helland; Hanna-Kirsti Schrøder Leiros; Ingar Leiros; Solveig Karlsen; Gry Evjen; Raimond Ravelli; Guy Schoehn; Rob Ruigrok; Ole Kristian Tollersrud; Seán McSweeney; Edward Hough
Journal:  J Mol Biol       Date:  2003-03-28       Impact factor: 5.469

9.  Spectrum of mutations in alpha-mannosidosis.

Authors:  T Berg; H M Riise; G M Hansen; D Malm; L Tranebjaerg; O K Tollersrud; O Nilssen
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

Review 10.  Alpha-mannosidosis.

Authors:  Dag Malm; Øivind Nilssen
Journal:  Orphanet J Rare Dis       Date:  2008-07-23       Impact factor: 4.123

  10 in total
  9 in total

1.  Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.

Authors:  Line Borgwardt; Hilde Monica Frostad Riise Stensland; Klaus Juul Olsen; Flemming Wibrand; Helle Bagterp Klenow; Michael Beck; Yasmina Amraoui; Laila Arash; Jens Fogh; Øivind Nilssen; Christine I Dali; Allan Meldgaard Lund
Journal:  Orphanet J Rare Dis       Date:  2015-06-06       Impact factor: 4.123

2.  Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.

Authors:  Line Borgwardt; Nathalie Guffon; Yasmina Amraoui; Christine I Dali; Linda De Meirleir; Mercedes Gil-Campos; Bénédicte Heron; Silvia Geraci; Diego Ardigò; Federica Cattaneo; Jens Fogh; J M Hannerieke Van den Hout; Michael Beck; Simon A Jones; Anna Tylki-Szymanska; Ulla Haugsted; Allan M Lund
Journal:  J Inherit Metab Dis       Date:  2018-05-30       Impact factor: 4.982

3.  Disease progression of alpha-mannosidosis and impact on patients and carers - A UK natural history survey.

Authors:  Jacqueline Adam; Rachel Malone; Sioned Lloyd; Jennifer Lee; Christian J Hendriksz; Uma Ramaswami
Journal:  Mol Genet Metab Rep       Date:  2019-06-08

4.  Long-term outcome of patients with alpha-mannosidosis - A single center study.

Authors:  Patryk Lipiński; Agnieszka Różdżyńska-Świątkowska; Katarzyna Iwanicka-Pronicka; Barbara Perkowska; Paulina Pokora; Anna Tylki-Szymańska
Journal:  Mol Genet Metab Rep       Date:  2021-12-09

Review 5.  Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature.

Authors:  Julia B Hennermann; Eva M Raebel; Francesca Donà; Marie-Line Jacquemont; Graziella Cefalo; Andrea Ballabeni; Dag Malm
Journal:  Orphanet J Rare Dis       Date:  2022-07-23       Impact factor: 4.303

6.  Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.

Authors:  Markus Damme; Stijn Stroobants; Meike Lüdemann; Michelle Rothaug; Renate Lüllmann-Rauch; Hans Christian Beck; Annika Ericsson; Claes Andersson; Jens Fogh; Rudi D'Hooge; Paul Saftig; Judith Blanz
Journal:  Ann Clin Transl Neurol       Date:  2015-09-19       Impact factor: 4.511

Review 7.  Bone health in patients with inborn errors of metabolism.

Authors:  M Langeveld; C E M Hollak
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

8.  Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.

Authors:  Allan M Lund; Line Borgwardt; Federica Cattaneo; Diego Ardigò; Silvia Geraci; Mercedes Gil-Campos; Linda De Meirleir; Cécile Laroche; Philippe Dolhem; Duncan Cole; Anna Tylki-Szymanska; Monica Lopez-Rodriguez; Encarna Guillén-Navarro; Christine I Dali; Bénédicte Héron; Jens Fogh; Nicole Muschol; Dawn Phillips; J M Hannerieke Van den Hout; Simon A Jones; Yasmina Amraoui; Paul Harmatz; Nathalie Guffon
Journal:  J Inherit Metab Dis       Date:  2018-05-03       Impact factor: 4.982

9.  Use of the Bruininks-Oseretsky test of motor proficiency (BOT-2) to assess efficacy of velmanase alfa as enzyme therapy for alpha-mannosidosis.

Authors:  Dawn Phillips; Julia B Hennermann; Anna Tylki-Szymanska; Line Borgwardt; Mercedes Gil-Campos; Nathalie Guffon; Yasmina Amraoui; Silvia Geraci; Diego Ardigò; Federica Cattaneo; Allan M Lund
Journal:  Mol Genet Metab Rep       Date:  2020-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.